Global Hyperpigmentation Treatment Market Grows Steadily at a CAGR of 6.45%

Introduction

Straits Research released its highly anticipated report, “Global Hyperpigmentation Treatment Market Size & Outlook, 2026-2034.” According to the study, the global market size is valued at USD 1.46 billion in 2025 and is projected to expand to USD 2.55 billion by 2034, registering a compound annual growth rate (CAGR) of 6.45%.

Market Dynamics

The market growth is primarily attributed to the rising prevalence of pigmentation disorders, advancements in laser and light-based therapies, as well as the introduction of topical formulations with natural as well as biotech-derived actives. In addition, technology innovations in lasers as well as energy-based devices have elevated the precision, safety, and accessibility of hyperpigmentation treatments, which further enhances the market growth. For example, in 2024, as per the Candela Corporation, the company introduced the PicoWay Resolve Fusion, which is a new laser device offering enhanced precision in pigmentation treatment. Such innovations are a major growth factor for clinics, healthcare providers, and the broader aesthetic dermatology industry. Moreover, the transition towards gentle, clean, or often plant-based or biotech-derived solutions in skin care presents as a significant market opportunity as these ingredients are safer, more inclusive, and often align with the demand for sustainable and natural beauty. For example, in March 2024, Givaudan Active Beauty launched Illuminyl 38, a biotech-enhanced molecule designed via cell-free glycosylation that addresses all the challenges of skin pigmentation for all skin types. Such a factor opens new avenues for brands to meet the evolving consumer values as well as regulatory trends.

Market Highlights

• Treatment Type: The Topical Treatments segment is estimated to grow at the fastest pace with a CAGR (7.31%) during the forecast period, driven by the rising consumer preference for non-invasive, cost effective, and easily accessible solutions.
• Application: The Age Spots segment dominated the market in 2025 with a revenue share of 37.11%. 
• Regional Insights: North America dominated the market with 86% share in 2025, driven by the presence of well-established dermatology clinics as well as cosmetic centers. 

Competitive Players

1. L'Oréal S.A.
2. Unilever
3. Beiersdorf AG
4. Candela Corporation
5. Obagi Cosmeceuticals LLC
6. SkinCeuticals
7. La Roche-Posay
8. Vivier Pharma Canada
9. iS Clinical
10. BIODERMA
11. CP Skin Health Group, Inc.
12. ISDIN
13. Shiseido Co., Ltd.
14. Uriage
15. Episciences, Inc.
16. Johnson and Johnson Innovation LLC
17. Procter and Gamble, Plz
18. Menarini Asia-Pacific Pte. Ltd.
19. Topicals
20. Image Skincare
21. Others

Recent Developments

Segmentation

1. By Treatment Type (2026-2034)
   1. Topical Treatments (Creams and Serums)
      1. Hydroquinone-based creams
      2. Retinoids
      3. Vitamin C serums
      4. Kojic acid creams
   2. Procedural Treatments
      1. Laser & Light-based Treatments
         1. Q-switched lasers
         2. Fractional lasers
         3. Intense Pulsed Light (IPL)
      2. Chemical Peels
         1. Glycolic acid peels
         2. Salicylic acid peels
         3. TCA peels
      3. Microneedling / PRP
2. By Application (2026-2034)
   1. Age Spots
   2. Melasma
   3. Post-inflammatory Hyperpigmentation (PIH)
   4. Freckles
   5. Others